243 related articles for article (PubMed ID: 38670466)
1. The influence of drug class on reward in substance use disorders.
Jones JD; Arout CA; Luba R; Murugesan D; Madera G; Gorsuch L; Schusterman R; Martinez S
Pharmacol Biochem Behav; 2024 Jul; 240():173771. PubMed ID: 38670466
[TBL] [Abstract][Full Text] [Related]
2. Neural mechanisms of the reinforcing action of cocaine.
Wise RA
NIDA Res Monogr; 1984; 50():15-33. PubMed ID: 6440023
[TBL] [Abstract][Full Text] [Related]
3. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
Panagis G; Vlachou S; Nomikos GG
Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
[TBL] [Abstract][Full Text] [Related]
4. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
Koob GF
Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review.
Karimi-Haghighi S; Chavoshinezhad S; Mozafari R; Noorbakhsh F; Borhani-Haghighi A; Haghparast A
Cell Mol Neurobiol; 2023 Mar; 43(2):649-682. PubMed ID: 35461410
[TBL] [Abstract][Full Text] [Related]
6. Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder.
Edwards S
Prog Brain Res; 2016; 223():63-76. PubMed ID: 26806771
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opioids and addiction to alcohol and other drugs of abuse.
Gianoulakis C
Curr Top Med Chem; 2004; 4(1):39-50. PubMed ID: 14754375
[TBL] [Abstract][Full Text] [Related]
8. Cell-type and projection-specific dopaminergic encoding of aversive stimuli in addiction.
Thibeault KC; Kutlu MG; Sanders C; Calipari ES
Brain Res; 2019 Jun; 1713():1-15. PubMed ID: 30580012
[TBL] [Abstract][Full Text] [Related]
9. Addictive drugs and brain stimulation reward.
Wise RA
Annu Rev Neurosci; 1996; 19():319-40. PubMed ID: 8833446
[TBL] [Abstract][Full Text] [Related]
10. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
Wee S; Koob GF
Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
[TBL] [Abstract][Full Text] [Related]
11. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
Patrono E; Gasbarri A; Tomaz C; Nishijo H
Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
[TBL] [Abstract][Full Text] [Related]
12. The Neuroscience of Drug Reward and Addiction.
Volkow ND; Michaelides M; Baler R
Physiol Rev; 2019 Oct; 99(4):2115-2140. PubMed ID: 31507244
[TBL] [Abstract][Full Text] [Related]
13. Addiction and brain reward and antireward pathways.
Gardner EL
Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.
Spanagel R
Dialogues Clin Neurosci; 2020 Sep; 22(3):241-250. PubMed ID: 33162767
[TBL] [Abstract][Full Text] [Related]
15. Drugs of abuse: biochemical surrogates of specific aspects of natural reward?
Di Chiara G; Acquas E; Tanda G; Cadoni C
Biochem Soc Symp; 1993; 59():65-81. PubMed ID: 7910742
[TBL] [Abstract][Full Text] [Related]
16. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
Pierce RC; Kumaresan V
Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
Maldonado R; Berrendero F
Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
[TBL] [Abstract][Full Text] [Related]
18. Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect.
Towers EB; Williams IL; Qillawala EI; Rissman EF; Lynch WJ
Pharmacol Rev; 2023 Mar; 75(2):217-249. PubMed ID: 36781217
[TBL] [Abstract][Full Text] [Related]
19. Adolescence versus adulthood: Differences in basal mesolimbic and nigrostriatal dopamine transmission and response to drugs of abuse.
Corongiu S; Dessì C; Cadoni C
Addict Biol; 2020 Jan; 25(1):e12721. PubMed ID: 30779271
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
